首页> 外文期刊>Current Protein and Peptide Science >Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance
【24h】

Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance

机译:消除卵巢癌干细胞:卵巢癌化学抗性的潜在治疗靶点

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Tumor recurrence followed by chemoresistance is a major cause of the poor survival rates for ovarian cancer. Despite advances in ovarian cancer chemotherapies and increased knowledge of the characteristics of ovarian cancer, chemoresistance is still an enormous clinical challenge. Current research suggests that ovarian cancer stem cells (OCSCs) might be involved in the occurrence of chemoresistance in ovarian cancer. In this review, we focus on the relationship of ovarian cancer stem cells with drug-resistant ovarian cancer phenotypes. We also discuss the current knowledge regarding ovarian cancer stem cell-based therapeutic strategies as attempts to overcome chemoresistance, the largest obstacle for successful treatment. Finally, we discuss methods for improving the treatment outcomes of ovarian cancer patients with chemoresistance.
机译:肿瘤复发后再进行化疗是卵巢癌生存率低的主要原因。尽管卵巢癌化学疗法取得了进展并且对卵巢癌的特征有了更多的了解,但化学抗药性仍然是巨大的临床挑战。当前的研究表明,卵巢癌干细胞(OCSC)可能参与了卵巢癌化学耐药性的发生。在这篇综述中,我们关注卵巢癌干细胞与耐药性卵巢癌表型的关系。我们还将讨论有关卵巢癌基于干细胞的治疗策略的当前知识,以克服化学抗药性,这是成功治疗的最大障碍。最后,我们讨论了提高卵巢癌化疗耐药性患者治疗效果的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号